Tuesday, May 12, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

The Midlife Market: How Menopause Care Finally Went Mainstream

From celebrity-backed brands to big-box beauty retailers, menopause is being rebranded as a visible, viable part of women's health—and commerce.

Ashley Rodgers by Ashley Rodgers
May 6, 2025
in Trends
0

In the quiet margins of healthcare, menopause has long stood as a gaping omission. A ubiquitous biological transition that affects over one billion women globally, menopause has been routinely treated more as a private affliction than a public health concern. But in recent years, that narrative is shifting—and dramatically so. The once-hushed vocabulary of hot flashes, night sweats, and hormone fluctuations is now being uttered across podcasts, Instagram reels, beauty counters, and venture-backed startups.

From Michelle Obama’s podcast reflections on the disorienting experience of menopause to Naomi Watts’ launch of Stripes, a brand dedicated to midlife women’s wellness, celebrities are not just talking about menopause—they’re building platforms around it. In Watts’ words, Stripes is about “amplifying a conversation that has been stifled by stigma,” a sentiment echoed by Halle Berry, who co-founded Respin Health, a holistic wellness platform inclusive of menopause-specific resources.

This celebrity-fronted movement is dovetailing with a broader commercialization of midlife wellness. Retail giants like Sephora and Ulta Beauty—once synonymous with youth-obsessed beauty culture—are now investing in shelf space for menopause-related products. Items such as estrogen-free moisturizers, hot flash cooling sprays, and sleep supplements are no longer tucked away in the corners of pharmacies; instead, they are merchandised under curated “Wellness for Every Stage” banners.

What we are witnessing is not simply a rebranding of menopause, but its strategic repositioning in the cultural and commercial mainstream. According to data from Grand View Research, the global menopause market was valued at $15.4 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 5.7% through 2030. This isn’t a passing trend; it’s a structural shift.

Yet the roots of this shift are as much sociocultural as they are economic. The average American woman reaches menopause at age 51—at the peak of her career and productivity. And with the U.S. Census Bureau projecting that by 2030, women aged 45 to 64 will make up nearly 25% of the adult female population, the stakes for better care, policy, and products are rising.

Despite this demographic shift, healthcare has lagged. A 2023 survey by the Mayo Clinic found that only 31% of women felt their healthcare providers were well-informed about menopause. Even among OB-GYNs, fewer than one in five residency programs in the United States include formal menopause training, according to the American College of Obstetricians and Gynecologists.

“The silence around menopause isn’t just social—it’s systemic,” explains Dr. Sharon Malone, a board-certified OB-GYN and menopause specialist. “We’ve treated it as a side effect of aging rather than a major health transition deserving of serious medical attention.”

This silence is now being broken by a new wave of femtech startups, social media communities, and policy advocates. While celebrity voices help destigmatize, it’s the convergence with scientific advocacy and consumer demand that gives this moment its momentum. Organizations like The Menopause Society (formerly the North American Menopause Society) are working to raise clinical standards and public awareness, while platforms like Gennev and Elektra Health offer telehealth services explicitly for menopause management.

But the movement also raises questions: Will this cultural pivot translate into better clinical outcomes? Or will menopause, like other aspects of women’s health, become commodified without improving equity or access?

Critics caution against what they see as the wellness-industrial complex wrapping midlife distress in aspirational packaging. “The danger lies in treating menopause like a lifestyle brand,” says Dr. Jen Gunter, OB-GYN and author of The Menopause Manifesto. “The medical complexity shouldn’t be lost in the marketing.”

Still, the significance of this shift can’t be dismissed. For too long, menopause has been a health blind spot. The new visibility—whether in a Netflix special, a Sephora aisle, or a TikTok tutorial—represents a collective recalibration of how society values aging, autonomy, and care.

In that recalibration, midlife women are finding more than just moisturizers and mood-balancing teas. They’re finding legitimacy. And perhaps, at last, the promise of informed, dignified care.

ShareTweet
Ashley Rodgers

Ashley Rodgers

Ashley Rodgers is a writer specializing in health, wellness, and policy, bringing a thoughtful and evidence-based voice to critical issues.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The 340B Coalition

    The 340B Coalition

    0 shares
    Share 0 Tweet 0
  • The Rebate That Ate the List Price

    0 shares
    Share 0 Tweet 0
  • Force of Impact in a Tackle

    0 shares
    Share 0 Tweet 0
  • Transparency Without Translation

    0 shares
    Share 0 Tweet 0
  • The Number Nobody Publishes

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy